SIGA to Appeal Adverse Small Business Size Determination
November 07, 2010 18:22 ET
|
SIGA Technologies Inc.
NEW YORK, Nov. 7, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
SIGA Technologies Reports Financial Results for the Third Quarter of 2010
November 02, 2010 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, Nov. 2, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today reported its...
SIGA to Discuss Third Quarter Results of Operations on November 2, 2010
October 29, 2010 12:30 ET
|
SIGA Technologies Inc.
NEW YORK, Oct. 29, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced today...
SIGA Selected for the Procurement of Smallpox Antiviral Drug for the Strategic National Stockpile and Responds to Small Business Size Protest
October 13, 2010 08:30 ET
|
SIGA Technologies Inc.
NEW YORK, Oct. 13, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
SIGA Technologies Reports Financial Results for the Second Quarter and First Half of 2010
August 05, 2010 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, Aug. 5, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced its...
SIGA to Discuss Second Quarter Results of Operations on August 5, 2010
August 02, 2010 08:30 ET
|
SIGA Technologies Inc.
NEW YORK, Aug. 2, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced today that...
SIGA Completes Fourth Successful Human Safety Clinical Trial
June 23, 2010 08:30 ET
|
SIGA Technologies Inc.
NEW YORK, June 23, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
Andy Stern Joins SIGA's Board of Directors
June 21, 2010 08:30 ET
|
SIGA Technologies Inc.
NEW YORK, June 21, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
SIGA CEO Dr. Eric Rose Addresses Congressional Appropriations Subcommittee on Behalf of the Alliance for Biosecurity
May 12, 2010 14:54 ET
|
SIGA Technologies Inc.
NEW YORK, May 12, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of drugs to fight biowarfare pathogens, today announced that its Chief...
Press Release Correction: SIGA Technologies Reports Operating Results for the First Quarter of 2010
May 04, 2010 19:21 ET
|
SIGA Technologies Inc.
NEW YORK, May 4, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of drugs to fight biowarfare pathogens, issued a correction of today's press...